177 related articles for article (PubMed ID: 28007907)
1. H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation.
Hasumi H; Hasumi Y; Baba M; Nishi H; Furuya M; Vocke CD; Lang M; Irie N; Esumi C; Merino MJ; Kawahara T; Isono Y; Makiyama K; Warner AC; Haines DC; Wei MH; Zbar B; Hagenau H; Feigenbaum L; Kondo K; Nakaigawa N; Yao M; Metwalli AR; Marston Linehan W; Schmidt LS
Hum Mol Genet; 2017 Jan; 26(2):354-366. PubMed ID: 28007907
[TBL] [Abstract][Full Text] [Related]
2. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
Hasumi H; Baba M; Hasumi Y; Lang M; Huang Y; Oh HF; Matsuo M; Merino MJ; Yao M; Ito Y; Furuya M; Iribe Y; Kodama T; Southon E; Tessarollo L; Nagashima K; Haines DC; Linehan WM; Schmidt LS
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1624-31. PubMed ID: 25775561
[TBL] [Abstract][Full Text] [Related]
3. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.
Hudon V; Sabourin S; Dydensborg AB; Kottis V; Ghazi A; Paquet M; Crosby K; Pomerleau V; Uetani N; Pause A
J Med Genet; 2010 Mar; 47(3):182-9. PubMed ID: 19843504
[TBL] [Abstract][Full Text] [Related]
4. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report.
Li J; Liu F; Liu X; Hu Y; Liu Z; Shen Y; Wan J
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.
Furuya M; Hasumi H; Baba M; Tanaka R; Iribe Y; Onishi T; Nagashima Y; Nakatani Y; Isono Y; Yao M
Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910
[TBL] [Abstract][Full Text] [Related]
7. A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic.
Enomoto Y; Namba Y; Hoshika Y; Komemushi Y; Mitani K; Kume H; Kobayashi E; Miyama Y; Homma Y; Ushiku T; Seyama K
Eur J Med Genet; 2020 Apr; 63(4):103820. PubMed ID: 31778855
[TBL] [Abstract][Full Text] [Related]
8. Birt-Hogg-Dubé: tumour suppressor function and signalling dynamics central to folliculin.
Tee AR; Pause A
Fam Cancer; 2013 Sep; 12(3):367-72. PubMed ID: 23096221
[TBL] [Abstract][Full Text] [Related]
9. Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.
Schmidt LS
Fam Cancer; 2013 Sep; 12(3):357-64. PubMed ID: 23108783
[TBL] [Abstract][Full Text] [Related]
10. Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.
Clausen L; Stein A; Grønbæk-Thygesen M; Nygaard L; Søltoft CL; Nielsen SV; Lisby M; Ravid T; Lindorff-Larsen K; Hartmann-Petersen R
PLoS Genet; 2020 Nov; 16(11):e1009187. PubMed ID: 33137092
[TBL] [Abstract][Full Text] [Related]
11. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
12. Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.
Houweling AC; Gijezen LM; Jonker MA; van Doorn MB; Oldenburg RA; van Spaendonck-Zwarts KY; Leter EM; van Os TA; van Grieken NC; Jaspars EH; de Jong MM; Bongers EM; Johannesma PC; Postmus PE; van Moorselaar RJ; van Waesberghe JH; Starink TM; van Steensel MA; Gille JJ; Menko FH
Br J Cancer; 2011 Dec; 105(12):1912-9. PubMed ID: 22146830
[TBL] [Abstract][Full Text] [Related]
13. Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.
Baba M; Furihata M; Hong SB; Tessarollo L; Haines DC; Southon E; Patel V; Igarashi P; Alvord WG; Leighty R; Yao M; Bernardo M; Ileva L; Choyke P; Warren MB; Zbar B; Linehan WM; Schmidt LS
J Natl Cancer Inst; 2008 Jan; 100(2):140-54. PubMed ID: 18182616
[TBL] [Abstract][Full Text] [Related]
14. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
[TBL] [Abstract][Full Text] [Related]
15. Birt Hogg-Dubé syndrome-associated FLCN mutations disrupt protein stability.
Nahorski MS; Reiman A; Lim DH; Nookala RK; Seabra L; Lu X; Fenton J; Boora U; Nordenskjöld M; Latif F; Hurst LD; Maher ER
Hum Mutat; 2011 Aug; 32(8):921-9. PubMed ID: 21538689
[TBL] [Abstract][Full Text] [Related]
16. Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome.
Benhammou JN; Vocke CD; Santani A; Schmidt LS; Baba M; Seyama K; Wu X; Korolevich S; Nathanson KL; Stolle CA; Linehan WM
Genes Chromosomes Cancer; 2011 Jun; 50(6):466-77. PubMed ID: 21412933
[TBL] [Abstract][Full Text] [Related]
17. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development.
Baba M; Keller JR; Sun HW; Resch W; Kuchen S; Suh HC; Hasumi H; Hasumi Y; Kieffer-Kwon KR; Gonzalez CG; Hughes RM; Klein ME; Oh HF; Bible P; Southon E; Tessarollo L; Schmidt LS; Linehan WM; Casellas R
Blood; 2012 Aug; 120(6):1254-61. PubMed ID: 22709692
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic characteristics of chinese patients with Birt-Hogg-Dubé syndrome.
Liu Y; Xu Z; Feng R; Zhan Y; Wang J; Li G; Li X; Zhang W; Hu X; Tian X; Xu KF; Zhang X
Orphanet J Rare Dis; 2017 May; 12(1):104. PubMed ID: 28558743
[TBL] [Abstract][Full Text] [Related]
19. Birt-Hogg-Dube syndrome is a novel ciliopathy.
Luijten MN; Basten SG; Claessens T; Vernooij M; Scott CL; Janssen R; Easton JA; Kamps MA; Vreeburg M; Broers JL; van Geel M; Menko FH; Harbottle RP; Nookala RK; Tee AR; Land SC; Giles RH; Coull BJ; van Steensel MA
Hum Mol Genet; 2013 Nov; 22(21):4383-97. PubMed ID: 23784378
[TBL] [Abstract][Full Text] [Related]
20. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.
Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
